| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | colistimethate sodium (ColiFin®) |
| Formulation | 1 MIU and 2 MIU powder and solvent for nebuliser solution |
| Reference number | 3277 |
| Indication | Management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult and paediatric patients with cystic fibrosis |
| Company | PARI Medical Ltd |
| BNF chapter | Infections |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 14/07/2016 |